Rapaflo

Product manufactured by Actavis Pharma, Inc.

Application Nr Approved Date Route Status External Links
NDA022206 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rapaflo, A Selective Alpha-1 Adrenergic Receptor Antagonist, Is Indicated For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia (bph) [ See Clinical Studies ( 14 ) ] . Rapaflo Is Not Indicated For The Treatment Of Hypertension. Rapaflo, An Alpha-1 Adrenergic Receptor Antagonist, Is Indicated For The Treatment Of The Signs And Symptoms Of Benign Prostatic Hyperplasia (bph). Rapaflo Is Not Indicated For The Treatment Of Hypertension. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Silodosin SILODOSIN ZINC3806063

Comments